These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1346404)

  • 81. The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
    Thangaraju M; Rameshbabu J; Vasavi H; Ilanchezhian S; Vinitha R; Sachdanandam P
    Mol Cell Biochem; 1998 Aug; 185(1-2):85-94. PubMed ID: 9746215
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells.
    Cai J; Lee CW
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):991-5. PubMed ID: 9003390
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.
    Kalef-Ezra JA; Pavlidis N; Klouvas G; Karantanas A; Hatzikonstantinou I; Glaros D
    Breast Cancer Res Treat; 1996; 37(2):161-8. PubMed ID: 8750583
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer.
    Brunner N; Spang-Thomsen M; Cullen K
    Breast Cancer Res Treat; 1996; 39(1):87-92. PubMed ID: 8738608
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer.
    Maenpaa J; Wiebe V; Koester S; Wurz G; Emshoff V; Seymour R; Sipila P; DeGregorio M
    Cancer Chemother Pharmacol; 1993; 32(5):396-8. PubMed ID: 8339392
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?
    Wiseman H; Paganga G; Rice-Evans C; Halliwell B
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):635-8. PubMed ID: 8317992
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antioxidant benefits of tamoxifen therapy for breast cancer?
    Wiseman H; Rice-Evans C; Halliwell B
    Breast Cancer Res Treat; 1994; 29(3):307. PubMed ID: 8049464
    [No Abstract]   [Full Text] [Related]  

  • 88. Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.
    Zhang JJ; Jacob TJ; Valverde MA; Hardy SP; Mintenig GM; Sepúlveda FV; Gill DR; Hyde SC; Trezise AE; Higgins CF
    J Clin Invest; 1994 Oct; 94(4):1690-7. PubMed ID: 7929848
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
    Callaghan R; Higgins CF
    Br J Cancer; 1995 Feb; 71(2):294-9. PubMed ID: 7841043
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue.
    Pujol H; Girault J; Rouanet P; Fournier S; Grenier J; Simony J; Fourtillan JB; Pujol JL
    Cancer Chemother Pharmacol; 1995; 36(6):493-8. PubMed ID: 7554041
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.
    Garcia M; Derocq D; Freiss G; Rochefort H
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11538-42. PubMed ID: 1454845
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trials.
    Jordan VC
    Prog Clin Biol Res; 1988; 262():105-23. PubMed ID: 3287387
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer.
    Jordan VC
    J Natl Cancer Inst; 1992 Feb; 84(4):231-4. PubMed ID: 1346404
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.
    Jordan VC
    Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.
    Wolf DM; Jordan VC
    Gynecol Oncol; 1992 May; 45(2):118-28. PubMed ID: 1592278
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
    Jordan VC
    Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.